General Information of the Compound
| Compound ID |
CP0431607
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-(3-methylphenyl)but-1-enyl]-5-oxopyrrolidin-1-yl]propyl]-1,3-oxazole-4-carboxylic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H26N2O5
|
||||||||||||||||||
| Molecular Weight |
398.459
|
||||||||||||||||||
| Canonical SMILES |
Cc1cccc(C[C@H](O)\C=C\[C@H]2CCC(=O)N2CCCc2nc(co2)C(O)=O)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H26N2O5/c1-15-4-2-5-16(12-15)13-18(25)9-7-17-8-10-21(26)24(17)11-3-6-20-23-19(14-29-20)22(27)28/h2,4-5,7,9,12,14,17-18,25H,3,6,8,10-11,13H2,1H3,(H,27,28)/b9-7+/t17-,18+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
KZBOXVCPDPJOSD-XJMNNFRSSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02988, Prostaglandin E2 receptor EP1 subtype
Protein ID: PT02989, Prostaglandin E2 receptor EP2 subtype
Protein ID: PT02345, Prostaglandin E2 receptor EP3 subtype
Protein ID: PT02346, Prostaglandin E2 receptor EP4 subtype